首页> 外文OA文献 >Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer
【2h】

Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer

机译:宫颈上皮内瘤变中ERK / MAP激酶途径的激活与病变等级有关,但与高危型人乳头瘤病毒,病毒清除率或宫颈癌预后无关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We subjected 302 archival samples (150 squamous cell carcinomas [SCCs] and 152 cervical intraepithelial neoplasia [CIN] lesions) to immunohistochemical staining with extracellular signal - regulated kinase-1 (ERK1) antibody and human papillomavirus (HPV) testing with 3 primer sets. Follow-up data were available for all SCC cases and 67 CIN cases. High-risk (HR) HPV types were associated with CIN (odds ratio [OR], 19.12; 95% confidence interval [CI], 2.31-157.81) and SCC (OR, 27.25; 95% CI, 3.28-226.09). There was a significant linear relationship between lesion grade and ERK1 staining intensity (P = .0001). ERK1 staining was a 100% specific indicator of CIN, with a 100% positive predictive value, but a poor predictor of HR HPV. ERK1 expression did not predict clearance or persistence of HR HPV after CIN treatment. ERK1 staining did not significantly predict survival in cervical cancer in univariate (P = .915) or multivariate analysis. After adjustment for HR HPV, stage, age, and tumor grade in the Cox regression model, only stage (P = .0001) and age (P = .002) remained independent prognostic factors. ERK1 expression seems to be an early marker of cervical carcinogenesis. ERK1 overexpression is not a specific marker of HR-HPV in CIN and cervical cancer, nor does it predict virus clearance after CIN treatment or disease outcome in cervical cancer.
机译:我们对302个档案样本(150个鳞状细胞癌[SCC]和152个宫颈上皮内瘤样变[CIN]病变)进行了免疫组织化学染色,采用了细胞外信号调节激酶1(ERK1)抗体,并使用3套引物对人乳头瘤病毒(HPV)进行了测试。所有SCC病例和67 CIN病例都有随访数据。高危(HR)HPV类型与CIN(比值比[OR]为19.12; 95%置信区间[CI]为2.31-157.81)和SCC(OR为27.25; 95%CI为3.28-226.09)相关。病变等级与ERK1染色强度之间存在显着的线性关系(P = .0001)。 ERK1染色是CIN的100%特异性指标,具有100%的阳性预测值,但对HR HPV的预测却很差。 CIN治疗后ERK1表达不能预测HR HPV的清除或持续存在。在单变量(P = .915)或多变量分析中,ERK1染色均不能显着预测宫颈癌的生存率。在Cox回归模型中调整HR HPV,分期,年龄和肿瘤等级后,只有分期(P = .0001)和年龄(P = .002)仍是独立的预后因素。 ERK1表达似乎是宫颈癌发生的早期标志。 ERK1过表达不是CIN和宫颈癌中HR-HPV的特异性标志物,也不能预测CIN治疗后的病毒清除率或宫颈癌的疾病结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号